Procter & GamblePGCOMMENTJun 06, 2017Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
There has been a move back into defensive stocks lately, which is how this would be categorized. It has some activist investors investing in the name. This has underperformed for years. You will do okay in the next little while, but he wouldn’t be a big, long-term holder of this. There is more money to be made in Tech or a more discretionary consumer name. There is not enough growth in this.